The Blood Grouping Reagents Market Size Value Per Capita in Belgium has exhibited fluctuating trends over the past decade. From 2012 to 2017, there was a general decline from 0.72% to 0.6%, followed by a recovery peaking at 0.76% in 2018, before stabilizing around 0.66% from 2019 to 2021, and slightly decreasing to 0.65% in 2022. The year-on-year variation saw a decrease from 2020 to 2022, indicating a recent stabilization in market value per capita. The compound annual growth rate (CAGR) over the last five years points to a relatively stable market with minor fluctuations.
Looking ahead, future trends for the Blood Grouping Reagents Market in Belgium may include advancements in technology that improve the efficiency and accuracy of blood typing, increased demand for personalized medicine, and a growing focus on transfusion safety. These factors could drive further development and expansion of the market.
| # | 13 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 2.14 | 2023 | View data | ||
| 2 | 2 United Kingdom | 1.64 | 2023 | View data | ||
| 3 | 3 Italy | 1.52 | 2023 | View data | ||
| 4 | 4 Greece | 1.35 | 2023 | View data | ||
| 5 | 5 Croatia | 1.01 | 2023 | View data | ||
| 6 | 6 Portugal | 0.9 | 2023 | View data | ||
| 7 | 7 Hungary | 0.84 | 2023 | View data | ||
| 8 | 8 Belgium | 0.65 | 2023 | |||
| 9 | 9 Poland | 0.59 | 2023 | View data | ||
| 10 | 10 Lithuania | 0.48 | 2023 | View data | ||
